Impact of Remdesivir on the Treatment of COVID-19 During the First Wave in Spain

INTRODUCTION: Spain was one of the most affected countries during the first wave of COVID-19, having the highest mortality rate in Europe. The aim of this retrospective study is to estimate the impact that remdesivir—the first drug for COVID-19 approved in the EU—would have had in the first wave. ME...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Adv Ther
Päätekijät: Soriano, Alejandro, Montejano, Rocío, Sanz-Moreno, José, Figueira, Juan Carlos, Grau, Santiago, Güerri-Fernández, Robert, Castro-Gómez, Antonio, Pérez-Román, Inés, Hidalgo-Vega, Álvaro, González-Domínguez, Almudena
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Springer Healthcare 2021
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8196270/
https://ncbi.nlm.nih.gov/pubmed/34118007
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-021-01804-9
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia